1. Home
  2. CNTA vs RLX Comparison

CNTA vs RLX Comparison

Compare CNTA & RLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • RLX
  • Stock Information
  • Founded
  • CNTA 2020
  • RLX 2018
  • Country
  • CNTA United Kingdom
  • RLX China
  • Employees
  • CNTA N/A
  • RLX N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • RLX Medicinal Chemicals and Botanical Products
  • Sector
  • CNTA Health Care
  • RLX Health Care
  • Exchange
  • CNTA Nasdaq
  • RLX Nasdaq
  • Market Cap
  • CNTA 2.3B
  • RLX 2.8B
  • IPO Year
  • CNTA 2021
  • RLX 2021
  • Fundamental
  • Price
  • CNTA $22.97
  • RLX $2.57
  • Analyst Decision
  • CNTA Strong Buy
  • RLX Hold
  • Analyst Count
  • CNTA 11
  • RLX 1
  • Target Price
  • CNTA $30.60
  • RLX $2.25
  • AVG Volume (30 Days)
  • CNTA 1.5M
  • RLX 4.6M
  • Earning Date
  • CNTA 11-11-2025
  • RLX 11-14-2025
  • Dividend Yield
  • CNTA N/A
  • RLX 0.40%
  • EPS Growth
  • CNTA N/A
  • RLX 12.15
  • EPS
  • CNTA N/A
  • RLX 0.08
  • Revenue
  • CNTA $15,000,000.00
  • RLX $407,348,055.00
  • Revenue This Year
  • CNTA N/A
  • RLX $27.26
  • Revenue Next Year
  • CNTA N/A
  • RLX $19.61
  • P/E Ratio
  • CNTA N/A
  • RLX $32.94
  • Revenue Growth
  • CNTA 118.88
  • RLX 55.36
  • 52 Week Low
  • CNTA $9.60
  • RLX $1.57
  • 52 Week High
  • CNTA $23.24
  • RLX $2.84
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 71.96
  • RLX 54.29
  • Support Level
  • CNTA $20.94
  • RLX $2.52
  • Resistance Level
  • CNTA $23.24
  • RLX $2.61
  • Average True Range (ATR)
  • CNTA 1.39
  • RLX 0.09
  • MACD
  • CNTA 0.41
  • RLX -0.01
  • Stochastic Oscillator
  • CNTA 96.72
  • RLX 20.51

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share

RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.

Share on Social Networks: